Fig. 1: Enrollment, randomization, and analysis populations. | Nature Communications

Fig. 1: Enrollment, randomization, and analysis populations.

From: A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease

Fig. 1

A total of 133 patients were screened, and 110 eligible patients underwent randomization and were included in the intention-to-treat population. In this study, 56 patients were assigned to receive cyclosporine plus corticosteroids and 54 patients were assigned to receive adalimumab plus corticosteroids. With the exception of 31 patients who discontinued intervention, a total of 79 patients were included in the per-protocol population.

Back to article page